Sanyou Biopharmaceuticals

Sanyou Biopharmaceuticals is a global leader in high-tech biotechnology, specializing in innovative biologics R&Dand services. Sanyou integrated 4C model - "differentiated CRO, integrated CDO, innovative CPO and characteristic CRS” bridges research and manufacturing, simplifying the discovery of groundbreaking biologics worldwide.

Sanyou has nearly 300 skilled professionals in drug development and industrialization. They have a fully equipped 20,000 square meters integrated lab and three industry-leading innovative technology platforms - “super-trillion, integration, and intelligence", and can offer customizable service to support client needs. Sanyou is committed to refining their proprietary platform and introducing upgraded services and technologies. With over 1000 global collaborations, Sanyou continues to actively collaborate with pharmaceutical companies, drug R&D institutions and diagnostics companies, cultivating a collaborative growth ecosystem and a thriving community with clients and partners.
www.sanyoubio.com / crs.sanyoubio.com

The prices are on request! Contact Us by e-mail info@sobekbio.com

Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab-MMAE) CHB301

The add to cart button will appear once you select the values above

Specifications

size	100 μg / 1 mg

Description:

Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab-MMAE)(CHB301) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 146.48 kDa.

Product type:

Antibody

Host:

CHO

Target name:

Siglec-2 / CD22

Target species:

Human

Isotype:

IgG

Buffer:

100 mM Pro-Ac 20 mM Arg pH5.0

Applications:

ELISA、FACS、Kinetics (BLI)、Kinetics (SPR)、Functional assay

More info:

Email: info@sobekbio.com

Orders:

Email: orders@sobekbio.com